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Abstract:

Introduction

Pathologic calcification is the principal
failure mode of bioprosthetic heart
valves
fabricated
from
glutaraldehyde
pretreated
porcine
aortic valves.
Bovine
pericardial
bioprosthetic valves also fail frequently by
calcification.
This review covers the novel
uses of the scanning electron microscope (SEM)
for investigating the pathology and prevention
of bioprosthetic heart valve calcification. The
progression and growth of calcific lesions in
the bioprosthetic heart valve tissues has been
documented
using
SEM
with
elemental
localization by energy dispersive X-ray analysis
(EDX).
Controlled release polymeric matrices
consisting of either ethanehydroxydiphosphonate,
FeC1 3
or
Al(N0 3 ) 3
coimplanted
with
bioprosthetic
tissue
prevent
experimental
bioprosthetic calcification. SEM has also been
used to study the drug particle distribution in
the controlled release matrices.
Furthermore,
matrix drug release in vitro and in vivo has
also been characterized and quantified using
SEM techniques.

Pathologic calcification is the principal
failure mode of bioprosthetic heart valves
fabricated from glutaraldehyde pretreated
porcine aortic valves.
Bovine pericardial
bioprosthetic valves also fail frequently by
calcification.
Currently there is no effective
therapy for this disease
process (Schoen et
al., 1988).
Bioprosthetic heart valve
calcification has been studied experimentally
in either subcutaneous (Levy et al., 1986) or
circulatory animal models (Barnhart et al.,
1982). These animal model systems yield
pathology comparable to clinical materials and
reproduce the important pathological features of
the intrinsic calcific lesions which lead to
valve failure.
These features, which include
cell and collagen oriented calcification,
ultimately lead to bulk mineral deposition
(Schoen and Levy, 1986).
Prevention of bioprosthetic heart valve
calcification by systemic administration of
anticalcification
agents
such
as
ethanehydroxydiphosphona te ( EHDP) leads to
severe side effects on bone formation (Levy et
al. , 198 7).
However, local therapy with EHDP
via coimplanted controlled release matrices
containing these drugs offers a means of
avoiding these problems.
Controlled release in
this context consists of drug dispersions within
polymer matrices.
The advantages of controlled
release therapy are the lower doses required by
drug delivery at the site of action, and the
effective concentrations far below toxic levels
due to constant regional release.
Controlled
release matrices containing EHDP (Golomb et al.,
1987), FeC1 3 or Al(N0 3 ) 3 (Pathak et al., In
Press) have been shown to be effective in
inhibiting
bioprosthetic
heart
valve
calcification in subdermal rat model.
The objectives of the present paper are to
review the uses of SEM techniques for
investigating bioprosthetic heart valve
calcification from both the mechanistic point of
view, and in terms of understanding controlled
release anticalcification therapy.
SEM
techniques were used to study the initial
deposition
of ca 1 c if i c deposits in the
subdermal bioprosthetic implants with respect to
the structure of the calcified valve tissue.
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SEM techniques were also
used to study the
extent and mechanism of in vitro and in vivo
drug release from polymeric matrices used for
the prevention of bioprosthetic heart valve
calcification.

the human cardiac valve (Gross and Kugel, 1931) .
Preparation of controlled release
polymeric
matrices
The ethylene vinyl acetate (EVA) EHDP
polymeric matrices were prepared by dispersing
EHDP (20% by weight) in EVA (20% weight by
volume)
and
casting
as
1
cm
diameter
hemispherical matrices (Levy et al., 1985).
This
geometric
structure
provides
nearly
constant release rates for various test drugs
(Hsieh et al.,
1983) .
Before the
release
studies, the matrices were coated with ethylene
vinyl acetate in methylene chloride (15%, w/v)
and air dried; a release aperture, 0.58 mm in
diameter, was drilled into the flat face of the
hemisphere . Scanning electron micrographs were
obtained of the pre- and post- in vitro release
polymeric matrices.
Carrier-free radiolabelled disodiurn r 14 c]
EHDP,
appropriately diluted with
unlabeled
disodium EHDP to yield a specific activity of
1330 dpm/µmol EHDP, was levigated into polymer
formulations for determining in vitro release of
EHDP (Golomb et al., 1987).
For implants,
circular (i.d . = 25 mm, o.d.= 31 mm) controlled
release matrices were formulated by levigating
disodium EHDP (90 to 106 µm particle size) into
Silastic 382 or Q-7 4840 at a 20% or 30%
concentration.
AlC1 3 and Fe C1 3 polymeric matr·c s
were
solvent cast in both Silastic
polyurethane
copolymer and Biomer (Pathak et al., in press).
Either, A1Cl 3 or Fe(N0 3 ) 3 both 10% by weight per
matrix)
and
the polymer
were
separately
dissolved into dimethylacetamide.
These two
solutions were mi x ed thoroughly together and
dried in a vacuum oven. The dried films were
0.54 ± 0.03 mm thick.
In vitro release studies
The in vitro release study of the EHDP
silicone
rubber drug delivery systems
was
conducted by incubating the matrices in 20 ml of
a physiologic buffer (0.1 M NaCl in 0.05 M
HEPES, pH 7.4) and a center, cross-sectional cut
of the matrix was obtained at 0,1,2,3,4 and 5
months.
The samples taken at various time
intervals
were
allowed to
dry
at
room
temperature before the analysis.
The samples
were mounted on stainless steel stubs
and
sputter-coated
with carbon.
Samples
were
analyzed for phosphorous and silicone .
The
release profiles of EHDP from the silicone
matrices
were determined by
using
energy
dispersive x-ray analysis (EDX)
coupled with
SEM and calculating the diphosphonate-associated
phosphorous (P) depleted from the polymer matrix
as a function of time.
EDX was conducted using
a Super 8000 Analyst (Kevex, Foster City, CA)
equippe d with a Kevex
system for elemental
localization which was coupled with a scanning
electron microscope (Hitachi, Model S-570, Santa
Clara,
CA).
Emitted X-rays for each element
were
collected
for 1.5 min.
the
counts
associated with the area under peak for each
element were calculated by a
deconvolution
routine
contained in the software
program
Quantex 1 (Myklebust et al., 1979) . The amount
of silicon in the silicone rubber based polymers
was used to normalize the phosphorous depletion

Experimental
Materials and Methods
Polydimethylsiloxane (Silastic 382,
Silastic Q-7 4840), and silicone rubber
polyurethane copolymer (Silastic 6605-41) were
obtained from Dow Corning (Midland, MI).
Ethylene vinyl acetate was procured from E.I.
DuPont (Wilmington, DE). Polyether polyurethane
(Biomer) was obtained from Ethicon (Somerville,
NJ). Nonradioactive and [ 14 c] labeled disodium
ethanehydroxydiphosphonate (EHDP)
were donated
by Procter and Gamble (Cincinnati, OH). Reagent
grade aluminum nitrate was obtained from Aldrich
(Milwaukee, WI), and
ferric chloride was
obtained
from
Fisher
(Fairlawn,
NJ).
Glutaraldehyde pretreated bovine pericardium
(GPBP) was prepared, as previously described
(Golomb et al., 1987):
fresh parietal
pericardium was obtained at slaughter from 2 to
3 week-old calves and immediately placed in iced
sterile saline.
Following dissection of
superficial fat from the external surfaces, the
tissue was crosslinked by incubating in 0 . 6%
glutaraldehyde solution in HEPES buffer (pH 7.4)
for 24 hrs and stored in 0.2% glutaraldehyde
solution in HEPES buffer (pH 7.4) at 4°c .
Glutaraldehyde pretreated porcine aortic valves
were also similarly prepared, as described in
detail elsewhere (Levy et al., 1983) .
In vivo implant protocols: Pathophysiology
studies
Male rats (CD strain, Charles River,
Burlington, MA) 21 days old, were anesthetized
with an intraperitoneal injection of ketamine
and Rompun. Subcutaneous pouches were created
over the anterior abdominal wall, an entire
valve cusp was implanted into two to four
subcutaneous pouches separated by at least 2 cm.
At predetermined time intervals, ten specimens
were explanted and
examined by light
microscopy, and chemically assayed for mineral
content (Golomb et al., 1987).
Two specimens
from each time point were analyzed by
transmission electron microscopy and four from
each time point were examined by scanning
electron microscopy with EDX.
The EDX was
performed on gold-coated glycol-methacrylate
sample blocks from which histologic sections
were prepared. Regions of interest were compared
with those of the associated light histology
slides (Schoen et al., 1985) . Data for each
valve sample consisted of the numbers of Ca and
P x-rays detected at each site (counts) during a
1-minute
interval minus background
spectra
obtained from an area of the plastic block
without tissue. This method is described in
detail elsewhere (Nelson et al., 1985). For each
valve,
several regions (lOOxlOO µm) of fibrosa
and spongiosa, separated by 500 to 1000 µm, were
analyzed.
The layered architecture of
the
porcine
aortic valve, previously
described
(Ferrans et al., 1978), is analogous to that of
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by comput ing the ratio of the counts associated
with the phosphorous peak to the counts observed
for the silicon (Si) peak for each sample at the
above specified time intervals and were compared
with a series of precisely formulated standards
of known composition (5%, 10%, 15%, 20% and 30%
w/w EHDP in silicone rubber).
The
results
obtained
from
EDX
were
also
correlated
with data obtained from parallel radioactive in
vitro re l ease studies using [ 4 c) EHDP (Johnston
et al., 1989).
In vivo implant protocols: Controlled release
To study the prevention of bioprosthetic
heart valve calcification by controlled release
polymeric matrices, in a separate set of animal
experiments,
subcutaneous pouches were created
in the rat abdomen as described above.
In these
pouches lxl cm pieces of either the GPBP alone
or attached to the controlled release drug
matrices containing EHDP or Al(N0 3 ) 3 or FeC1 3
were implanted.
After 21 days,
rats
were
sacrificed with co 2 asphyxiation and the GPBP's
exp lanted, lyophilized and hydrolyzed in 6N HCl,
using established procedures.
Calcium levels
were determined on aliquots of the hydrolysates
by
atomic
absorption
spectroscopy.
The
explanted polymeric matrices were studied by SEM
to elucidate the possible in vivo mechanism of
r e leas e of the drug from the matrices.
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Semi-guantitive assessment of morphology and
distribution of mineralization
In the rat subdermal model, the onset of
calcification was noted by 48 hours with both
the light and electron microscopy (Schoen et
a l., 1985). Mineral deposits were not observed
in specimens implanted for only 24 hrs.
Early
calcific deposits were small and punctate;
they
a ppeared to be associated with porcine aortic
valve connective tissue cells diffusely in both
the valve spongiosa and fibrous elements.
The
number of sites calcified, as demonstrated by
EDX as well as the size of individual deposits,
increased
with
time, principally
in
the
spongiosa. Ultrastructural examination revealed
both cell-associated and
collagen-associated
mineralization.
Early calcium deposits were
noted in devitalized porcine connective tissues,
in the cytoplasm, or associated with the plasma
membrane itself.
Early deposits did not involve
collagen bundles.
Cell associated
calcific
deposits became widespread and prominent over
the course of the first 21 days.
Although early mineral deposits occurred in
both
valvular fibrosa and
spongiosa,
EDX
confirmed
that
the
spongiosa
was
the
preferential site of localization for advanced
calcific deposits.
The concentrations of both
calcium and phosphorous in the spongiosa and
fibrosa are shown in Figure 1. With increasing
duration of implantation,
there was
little
change apparent in the concentration of both Ca
and P within the fibrous elements, but the
spongiosa continued to accumulate mineral.
EDX
demonstrated early saturation of fibrosa with
calcium by 7 days of implantation . In contrast,
calcium in the spongiosa increased markedly with

0
0

10

15

20

25

TIME (da y s)

Figure 1 . Site specific time dependence of
calcium and phosphorus concentrations as
de t e rm i n e d b y E DX on e x p 1 an t e d p o r c i n e
bioprosthetic heart valve leaflets retrieved
from rat subdermal implants.
A) Absolute EDX
counts of calcium and phosphorus; B) EDX count
ratio of spongiosa to fibrosa, for both calcium
and phosphorus (reproduced with permission from
Schoen et al., 1985)

time.
The EDX count ratio
of
elemental
concentrations in spongiosa to those in fibrosa
increased progressively throughout the 21 days
of implantation.
Assessing the mechanism of polymeric matrix drug
release in vitro
SEM has been valuable for elucidating the
in vitro progression of drug release
from
polymeric matrices.
Prior work has demonstrated
the utility of SEM imaging of a variety of
matrix substrates and dispersed drugs.
For
example,
studies of ethylene
vinylacetatedisodium ethane hydroxy diphosphonate (EVA-EHDP)
revealed that uniform sustained release of EHDP
was observed for more than 600 hours in vitro,
with only 12% cumulative release by this time
(Figure
2)
(Levy et al., 1985).
Scanning
electron micrographs of unimplanted matrices of
EVA-EHDP showed a uniform distribution of EHDP
particles ranging from 1 to 10
µm.
After
release of EHDP in vitro,
scanning electron
microscopy showed formation of cavities and
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Figure 2. Cumulative percentage of EHDP released from an ethylene-vinyl acetate EHDP matrix. Polymer matrices
contammg [14 C)EHDP were incubated at 37 ° C in 0.1 M NaH 2 P0 4 , pH 7.4. Inserts: scanning electron microscopy was
performed on specimens before release and after 42 days of release in. vitro. Drug particles (disodium EHDP) ranged in size
from 1 to 10 µm (reproduced with permission from Levy et al., 1985).
Figure 3. Post in vitro release scanning electron micrograph (A) and X-ray elemental microanalysis maps (B, C and D
respectively for calcium, phosphorus and silicon) of a matrix containing 30% (W /W) drug, 50:50 CaiEHDP: Na 2 EHDP
demonstrating element-specific drug particle and polymer spatial distribution (reproduced with permission from Golomb et
al., 1987).
100

-associated phosphorus (P) depleted from the
polymer matrix as a function of time .
Studies
of matrices containing equal molar amounts of
Na 2 EHDP and CaEHDP(l:l) demonstrated in vitro
release in complete agreement with control data
obtained by matrix weight change, and release of
Na 2 [ 14 c] EHDP.
Figure 4 illustrates cumulative
release profiles obtained by each of these three
methods;
these document the reliability of the
EDX approach.
Furthermore the SEM EDX technique just
described has been most useful in assessing
residual drug in estimating the in vivo release
from
the
matrices
explanted
from
the
circulation . Silicone rubber controlled release
matrices containing Na 2 EHDP were coimplanted in
the
sheep circulation as
tricuspid
valve
replacements,
to assess the efficiency of this
agent
in
inhibiting
bioprosthetic
tissue
calcification. These matrices were efficacious
without adverse effects and their residual drug
was readily determined with EDX.
In
vivo
explant analysis of EHDP matrices using EDX
revealed 79.0± 4.82 cumulative percent EHDP
released for matrices containing Na 2 EHDP (1:1)
after
120-150
days.
These
results
were
comparable
to the in vitro data
reported
elsewher~+(Johnsto~+et al., 1989).
Al
or Fe
controlled release
from
polyurethane or polyurethane-silicone
rubber
copolymer
matrices was also effective
for
inhibition of GPBP calcification in the rat
subdermal model, with no adverse effects (Pathak
et al., In Press). Hydrophilic polymers such as
polyurethanes and silicone rubber-polyurethane
copolymers have unique controlled release matrix
properties, which can be elucidated with SEM.
For
example,
the prerelease study of
the
Al(N0 3 ) 3
in Biomer matrices and FeC1 3
in
silicone rubber-polyurethane matrices revealed
that the Al(N0 3 ) 3 had formed a solution in the
polymer,
while the
FeC1 3
was
uniformly
dispersed as particles in the polymeric matrix
(Figure 5). However, post in vivo release SEM
of
each
of the two
types
of
matrices
demonstrated comparable cavitation and surface
erosion (Figure 5). Thus,
the comparatively
faster release rates from the
polyurethane
polymers are most likely due to the greater
water permeability of this material compared to
silicone rubber-polyurethane copolymer.
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Figure 4. Typical in vitro release profiles of
EHDP from a silicone rubber-EHDP circular drug
delivery matrix (30% w/w Na 2 EHDP and ca 2 EHDP
1:1) '
Determination by electron microprobe
analysis,
( • ) determination by release of Na 2 f 1 4 c]EHDP,
and
( • ) determination by following overall decline
in matrix weight.
(reproduced with permission from Johnston et al.,
1989).

(+)

tortuous canals due to the dissolution and
release of EHDP particles from the matrices.
SEM has also been useful for elucidating
the controlled release mechanism of a mixture of
disodium EHDP and the less soluble salt, CaEHDP
from a silicone rubber matrix. A post release
SEM (Fig. 3A) demonstrates cavitation, but a Ca EDX map shows sparing of the CaEHDP particles
(Fig.
3B) in comparison with the P-EDX (Fig.
3C), which demonstrates predominantly the CaEHDP
phosphorus emissions.
The Si-EDX (Fig. 3D) map
is useful for demonstrating the
background
polymer matrix substrate.
Scanning electron microscopy in quantifying and
evaluating controlled release matrices: In vivo
results
SEM coupled with EDX has also been useful
for documenting the extent of in vivo drug
release using elemental specific x-ray emissions
in a semiquantitative method.
For example,
residual drug remaining in silicone rubber can
not be determined through any extraction or
dissolution procedures . However, the in vitro
drug release of EHDP from silicone
rubber
monolithic matrices was also studied using EDX
analysis
by calculating
the
diphosphonate

Conclusions
It is concluded that SEM coupled with EDX
is useful for investigating the pathogenesis and
prevention
of
bioprosthetic
heart
valve
calcification.
SEM-EDX has provided
semi-
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Figure 5. Scanning electron micrograph of pre (A) and post (B) in vivo
release Al(N0 3 ) 3 polymeric matrices (in polyether polyurethane polymer:
Biomer ) showing the complete solution of the drug in the matrix material
(A); the post in vivo release micrograph (B) shows the particle swelling,
drug dissolution and cavitation phenomena during release. The FeC1 3 polymer
( in silicone rubber-polyurethane copolymer) scanning electron micrographs
show the uniform particle dispersion of the drug in the matrix pre release
(C),
while a comparable release mechanism (D) to Al(N0 3 ) 3 (B) is observed
in the post in vivo release polymer (Bar=2 micrometers).
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quantitative documentation of the progression of
GPBP calcification.
In addition SEM and SEM-EDX
have helped to elucidate the mechanism of drug
release
from controlled
release
polymeric
matrices.
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kinetics of release, I should think that the
simple
weighing would be far simpler
and
therefore the more expeditious approach.
Authors:
Our data presented in Figure
4
conclusively showed that the EDX results agree
very nicely with results obtained by weighing.
However, the weighing technique is only suitable
when an entire drug delivery matrix can be
retrieved intact from either an experiment or a
clinical retrieval. For a variety of reasons,
this was almost never possible in our series of
circulatory
explants,
therefore
the
EDX
microanalysis approach proved to be exceedingly
useful.

I_,_ !:L_ Lupinetti:
Do the treatment methods for
prevention
of
calcification
decrease
the
ultimate quantity of calcium deposits on the
valves, or merely shift the time course of
calcification to a certain degree?
Authors:
The treatment and methods described
would prevent calcification according to their
various specific mechanisms of action.
For
example, diphosphonates are known to restrict
hydroxyapatite crystal growth. Therefore,
the
ultimate bulk quantity of calcium phosphates
deposited on the valves would be
limited .
Furthermore, Al 3 + and Fe 3+ are thought
to
inhibit
calcification by blocking
cellular
initiation
sites.
Therefore,
the
ultimate
quantity of calcification would also be limited,
rather than a mere shifting of the time course.

H.C. Anderson:
What was the rationale for
adding aluminum nitrate versus ferric chloride?
Are
these substances active in
preventing
prostheses calcification or do they simply mimic
the dissolution pattern of EHDP?
Authors:
The rationale for studying
both
aluminum and ferric salts was based upon recent
results in our laboratory demonstrating that
both metallic salts have comparable efficacy for
inhibiting
bioprosthetic
heart
valve
calcification in preincubation studies (Webb et
al., 1990) . Preliminary results demonstrate thus
far that their mechanism of action has to do
with a high affinity association with the cell
membranes of the devitalized cells within the
bioprosthetic heart valve tissue. The reported
controlled release results, using either ferric
or
aluminum salts, demonstrate
the
first
successful
efforts
toward
sustained
drug
delivery of these compounds. Their mechanism of
action
is undoubtedly very different
from
ethanehydroxydiphosphonate (EHDP), since this
compound most likely inhibits calcium phosphate
crystal growth, and has not been shown to have
any specific affinity or association with cell
membranes.
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